Literature DB >> 18631773

Corticobasal degeneration: clinical aspects.

Thomas H Bak1, John R Hodges.   

Abstract

Mesh：

Year:  2008        PMID： 18631773     DOI： 10.1016/S0072-9752(07)01247-X

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  17 in total

1.  Prevalence and clinical characteristics of corticobasal syndrome with an initial symptom outside of the upper limb.

Authors:  Yuki Sakamoto; Toshio Shimizu; Shinsuke Tobisawa; Eiji Isozaki
Journal:  Neurol Sci       Date:  2017-02-11       Impact factor: 3.307

Review 2.  Corticobasal degeneration: a pathologically distinct 4R tauopathy.

Authors:  Naomi Kouri; Jennifer L Whitwell; Keith A Josephs; Rosa Rademakers; Dennis W Dickson
Journal:  Nat Rev Neurol       Date:  2011-04-12       Impact factor: 42.937

3.  Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.

Authors:  Ji Hyun Ko; Chong Sik Lee; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

4.  The association of aphasia and right-sided motor impairment in corticobasal syndrome.

Authors:  Johannes Levin; Thomas H Bak; Axel Rominger; Erik Mille; Thomas Arzberger; Armin Giese; Nibal Ackl; Stefan Lorenzl; Benedikt Bader; Maximilian Patzig; Kai Bötzel; Adrian Danek
Journal:  J Neurol       Date:  2015-07-05       Impact factor: 4.849

5.  Pathological staging of frontotemporal lobar degeneration.

Authors:  Jillian J Kril; Glenda M Halliday
Journal:  J Mol Neurosci       Date:  2011-05-07       Impact factor: 3.444

6.  Accuracy of death certificates for recording parkinsonian syndromes and associated dementia.

Authors:  Hanxu Shi; Carl Counsell
Journal:  J Neurol       Date:  2020-07-31       Impact factor: 4.849

7.  Criteria for the diagnosis of corticobasal degeneration.

Authors:  Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner
Journal:  Neurology       Date:  2013-01-29       Impact factor: 9.910

8.  Measuring disease progression in corticobasal syndrome.

Authors:  Nancy Huang; Michael Hornberger; John R Hodges; James R Burrell
Journal:  J Neurol       Date:  2014-06-04       Impact factor: 4.849

Review 9.  Genetic pleiotropy and the shared pathological features of corticobasal degeneration and progressive supranuclear palsy: a case report and a review of the literature.

Authors:  James Rini; Breton Asken; Ethan Geier; Katherine Rankin; Joel Kramer; Adam Boxer; Bruce Miller; Jennifer Yokoyama; Salvatore Spina
Journal:  Neurocase       Date:  2021-03-23       Impact factor: 0.881

10.  A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.

Authors:  N K Magdalinou; R W Paterson; J M Schott; N C Fox; C Mummery; K Blennow; K Bhatia; H R Morris; P Giunti; T T Warner; R de Silva; A J Lees; H Zetterberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-01-14       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.